{"id":475322,"date":"2021-04-13T08:03:24","date_gmt":"2021-04-13T12:03:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/"},"modified":"2021-04-13T08:03:24","modified_gmt":"2021-04-13T12:03:24","slug":"waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/","title":{"rendered":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization<\/b><\/p>\n<p class=\"bwalignc\"><i>Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Waters LC-MS Instrumentation and Genovis SmartEnzymes<\/i><\/p>\n<p><b>NEWS SUMMARY:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nCollaboration intended to bring speed and simplicity to bio-characterization workflows\n<\/li>\n<li>\nAutomated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories\n<\/li>\n<li>\nWaters and Genovis share goal of advancing the science behind the analysis of glycoproteins and protein therapeutics\n<\/li>\n<\/ul>\n<p>MILFORD, Mass. &amp; LUND, Sweden&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nWaters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters\u2122 <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fwaters%2Fen_US%2FBioAccord-LC-MS-System-for-Biopharmaceuticals%2Fnav.htm%3Fcid%3D135005818%26locale%3Den_US&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=BioAccord%26%238482%3B+LC-MS+System&amp;index=1&amp;md5=4bb93aceaae0c0b5cfdaca2dded31eca\">BioAccord\u2122 LC-MS System<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.andrewalliance.com%2Fpipetting-robot%2F&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Andrew%2B+pipetting+robot&amp;index=2&amp;md5=814657fd4e85d5e7c3f474d2fda986f0\">Andrew+ pipetting robot<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.genovis.com%2F&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Genovis+SmartEnzymes%26%238482%3B&amp;index=3&amp;md5=c769e82077755d8edc8f9d31123238e6\">Genovis SmartEnzymes\u2122<\/a>. The goal of the collaboration is to develop automated workflows for the rapid and consistent characterization of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs in bioprocess development, formulation, stability testing and quality control (QC).\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20210413005369\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210413005369\/en\/<\/a><\/p>\n<p>\n\u201cBiologics analysis is an area that is ripe for improvement. What takes analytical scientists several days to do, should take hours or minutes instead,\u201d said Jeff Mazzeo, Vice President, Global Marketing and Scientific Operations, Waters Corporation. \u201cToday, up-front sample preparation is a major bottleneck to productivity, largely due to the number of manual steps involved and the outmoded technology by which samples are readied for analysis. By combining Genovis\u2019 SmartEnzymes with automation, liquid chromatography\/time-of-flight mass spectrometry and application-specific software workflows from Waters, we intend to move biotherapeutic analysis forward in ways never thought possible.\u201d\n<\/p>\n<p>\n\u201cThe BioAccord LC-MS system and the Andrew+ pipetting robot align perfectly with our strategies and vision at Genovis to bring simplified, robust and automated enzyme-driven workflows to the biopharma industry,\u201d said Fredrik Olsson, CEO, Genovis AB. \u201cThe enzymatic workflows that we will develop in collaboration with Waters will help our customers in their efforts to bring safe and novel therapeutics to patients, faster.\u201d\n<\/p>\n<p>\nThe workflows in development are based on the pairing of the Waters BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes and will focus on addressing the application needs of GxP laboratories in the following areas:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nProduct variant analysis [e.g. glycosylation, oxidation]\n<\/li>\n<li>\nBioprocess stability monitoring\n<\/li>\n<li>\nBiosimilar glycosylation analysis\n<\/li>\n<\/ul>\n<p><b>Additional Resources<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nVisit the Waters web site for information on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fwaters%2Fen_US%2FBioAccord-LC-MS-System-for-Biopharmaceuticals%2Fnav.htm%3Fcid%3D135005818%26locale%3Den_US&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=BioAccord+LC-MS+System+for+Biopharmaceuticals&amp;index=4&amp;md5=baa32d80c7fc98499b6b295e2160dc26\">BioAccord LC-MS System for Biopharmaceuticals<\/a><\/li>\n<li>\nWatch the video <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvideos.waters.com%2Fdetail%2Fvideos%2Fbioaccord-system-demo%2Fvideo%2F6220164373001%2Fmulti-attribute-method-overview-%257C-bioaccord-system-demo-series-%257C-part-1-of-5%3FautoStart%3Dtrue&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Multi-Attribute+Method+Overview&amp;index=5&amp;md5=254f8d93710d3f5ab214a652b8db5d03\">Multi-Attribute Method Overview<\/a><\/li>\n<li>\nVisit the Genovis AB web site for information on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.genovis.com%2F&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Genovis+SmartEnzymes&amp;index=6&amp;md5=5e6e9ca0b9d76ddefd41833b6ccefc88\">Genovis SmartEnzymes<\/a><\/li>\n<li>\nRead the Genovis blog post <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.genovis.com%2Fblog%2Fgenovis-teams-up-with-waters-to-deliver-enzymatic-workflows-for-the-biopharma-industry%2F&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Genovis+Teams+up+with+Waters+to+Deliver+Enzymatic+Workflows+for+the+Biopharma+Industry&amp;index=7&amp;md5=443085a523389588b286394a42846af5\">Genovis Teams up with Waters to Deliver Enzymatic Workflows for the Biopharma Industry<\/a><\/li>\n<li>\nVisit the Andrew Alliance website for information on the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.andrewalliance.com%2Fpipetting-robot%2F&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Andrew%2B+Pipetting+Robot&amp;index=8&amp;md5=9e23bbc11916b8c59e56012b667d2ceb\">Andrew+ Pipetting Robot<\/a><\/li>\n<\/ul>\n<p><b>About Genovis <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.genovis.com%2F&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=%28www.genovis.com%29&amp;index=9&amp;md5=d966fc7fcd78f32a3fe0005eb37a06b6\">(www.genovis.com)<\/a><\/p>\n<p>\nGenovis\u2019 business concept is to apply its knowledge and customer driven innovation to design and provide tools for the development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes all over the world in innovative product formats that facilitate development and quality control of biological drugs. The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (US). Genovis shares are listed on Nasdaq First North Growth Market and Erik Penser Bank is the Company\u2019s Certified Adviser, <a rel=\"nofollow\" href=\"mailto:certifiedadviser@penser.se\">certifiedadviser@penser.se<\/a>, tel: +46 (0)8-463 83 00.\n<\/p>\n<p><b>About Waters Corporation<\/b> (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.waters.com&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=www.waters.com&amp;index=10&amp;md5=baa9c7b3357724da4e779eef30b916b5\">www.waters.com<\/a>)\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fnextgen%2Fus%2Fen.html&amp;esheet=52410591&amp;newsitemid=20210413005369&amp;lan=en-US&amp;anchor=Waters+Corporation&amp;index=11&amp;md5=e2ef32662463e3a5afaff4e77838bf0c\">Waters Corporation<\/a> (NYSE:WAT), the world&#8217;s leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food and environmental sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.\n<\/p>\n<p>\nWaters, BioAccord, SmartMS, Andrew Alliance and waters_connect are trademarks of Waters Corporation. SmartEnzymes is a trademark of the Genovis Group.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210413005369\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210413005369\/en\/<\/a><\/span><\/p>\n<p><b>Waters Contact:<\/b><\/p>\n<p>\nBrian J. Murphy<br \/>\n<br \/>PR Manager, Corporate Communications<br \/>\n<br \/>Waters Corporation<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:brian_j_murphy@waters.com\">brian_j_murphy@waters.com<br \/>\n<\/a><br \/>+1 508-482-2614\n<\/p>\n<p><b>Genovis Contact:<\/b><\/p>\n<p>\nFredrik Olsson<br \/>\n<br \/>CEO, Genovis AB<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:fredrik.olsson@genovis.com\">fredrik.olsson@genovis.com<br \/>\n<\/a><br \/>+46 70-276 46 56\n<\/p>\n<p><b>KEYWORDS:<\/b> Europe Sweden United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Technology Other Health Health Pharmaceutical Other Science Other Technology Medical Devices Research Software Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210413005369\/en\/560437\/3\/Waters_logo_K.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210413005369\/en\/870876\/3\/genovis_logo_rgb_1200px.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Waters LC-MS Instrumentation and Genovis SmartEnzymes NEWS SUMMARY: Collaboration intended to bring speed and simplicity to bio-characterization workflows Automated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories Waters and Genovis share goal of advancing the science behind the analysis of glycoproteins and protein therapeutics MILFORD, Mass. &amp; LUND, Sweden&#8211;(BUSINESS WIRE)&#8211; Waters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters\u2122 BioAccord\u2122 LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes\u2122. The goal of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-475322","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Waters LC-MS Instrumentation and Genovis SmartEnzymes NEWS SUMMARY: Collaboration intended to bring speed and simplicity to bio-characterization workflows Automated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories Waters and Genovis share goal of advancing the science behind the analysis of glycoproteins and protein therapeutics MILFORD, Mass. &amp; LUND, Sweden&#8211;(BUSINESS WIRE)&#8211; Waters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters\u2122 BioAccord\u2122 LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes\u2122. The goal of the &hellip; Continue reading &quot;Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-13T12:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization\",\"datePublished\":\"2021-04-13T12:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/\"},\"wordCount\":701,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/\",\"name\":\"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-04-13T12:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/","og_locale":"en_US","og_type":"article","og_title":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization - Market Newsdesk","og_description":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Waters LC-MS Instrumentation and Genovis SmartEnzymes NEWS SUMMARY: Collaboration intended to bring speed and simplicity to bio-characterization workflows Automated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories Waters and Genovis share goal of advancing the science behind the analysis of glycoproteins and protein therapeutics MILFORD, Mass. &amp; LUND, Sweden&#8211;(BUSINESS WIRE)&#8211; Waters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters\u2122 BioAccord\u2122 LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes\u2122. The goal of the &hellip; Continue reading \"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-13T12:03:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization","datePublished":"2021-04-13T12:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/"},"wordCount":701,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/","name":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-04-13T12:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210413005369r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-and-genovis-collaborate-to-develop-efficient-workflows-for-biopharmaceutical-characterization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/475322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=475322"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/475322\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=475322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=475322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=475322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}